List view / Grid view
8 February 2011 | By Johnson & Johnson
Johnson & Johnson and Crucell N.V. provide further information regarding Johnson & Johnson's proposed acquisition of Crucell...
8 February 2011 | By Kapler Communications
New white paper from Malvern examines benefits of real-time analysis for process development...
7 February 2011 | By AstraZeneca
AstraZeneca today announced that the phase III ENTHUSE Study 15...
7 February 2011 | By AstraZeneca
This study is in addition to the companies’ Phase III RENAISSANCE programme for TC-5214...
4 February 2011 | By AstraZeneca
AstraZeneca announced today that the US FDA has acknowledged receipt of the company’s reply to the Complete Response Letter (CRL) for the ticagrelor New Drug Application (NDA)...
3 February 2011 | By NextPharma Technologies
NextPharma the leading European provider of product development, contract manufacturing and cold chain and logistics outsourcing services to the pharmaceutical and biotech industry, is pleased to announce the appointment of Brigitte Genard as Quality Director at its sterile contract development and manufacturing site in Braine-l’Alleud, Belgium.
3 February 2011 | By Aesica Pharmaceuticals
Following the recent announcement that it has signed contracts ahead of acquiring three manufacturing sites from UCB, Aesica Pharmaceuticals has appointed a team...
3 February 2011 | By PwC
PwC has announced the appointment of Andrew Packman as head of the firm’s UK pharmaceutical and life sciences business...
2 February 2011 | By kdm communications limited
Plans include the generation and analyzing of sequence data, and to provide the samples and to host a new, free public database...
1 February 2011 | By The Scott Partnership
New measures will help drive down sponsor costs within clinical trials...
1 February 2011 | By Valeant Pharmaceuticals International Inc.
Valeant Pharmaceuticals International, Inc. and PharmaSwiss S.A. announced today that they have signed a binding agreement for Valeant to acquire PharmaSwiss...
1 February 2011 | By Karen Taylor PR
Jonathan Byrne has been appointed General Manager of Owen Mumford’s Cotswold Division...
1 February 2011 | By AstraZeneca
The European Commission has granted marketing authorisation to FLUENZ Influenza Vaccine...
31 January 2011 | By The Scott Partnership
Optibrium will be providing a sneak preview of the next generation of StarDrop at the Molecular Medicine Tri-Conference 2011...
31 January 2011 | By kdm communications limited
The reagents are initially being offered for sale in the USA, for use with the Infinite M1000 and Infinite 200 PRO series readers...
